Showing results (141-150 of 324) with videos related to
Sort By:
Pageof 33
European Journal of Radiology|September 28, 2025
Multimodal radiomic analysis to determine high-Consistency prognostic phenotypes associated with epidermal growth factor receptor mutations in non-small cell lung cancer brain metastasesChe-Yu Hsu, Hsin-Han Tsai, Ting-Li Chen, et al.Lung Cancer (Amsterdam, Netherlands)|May 3, 2008
Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma--a randomized phase II trialChiun Hsu, Sung-Hsin Kuo, Fu-Chang Hu, et al.International Journal of Cancer|September 10, 2005
Epidermal growth factor receptor mutations in needle biopsy/aspiration samples predict response to gefitinib therapy and survival of patients with advanced nonsmall cell lung cancerJin-Yuan Shih, Chien-Hung Gow, Chong-Jen Yu, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 25, 2012
Effusion immunocytochemistry as an alternative approach for the selection of first-line targeted therapy in advanced lung adenocarcinomaTzu-Hsiu Tsai, Shang-Gin Wu, Yih-Leong Chang, et al.Lung Cancer (Amsterdam, Netherlands)|November 11, 2008
EGFR intron 1 dinucleotide repeat polymorphism is associated with the occurrence of skin rash with gefitinib treatmentChin-Lun Huang, Chih-Hsin Yang, Kun-Huei Yeh, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 3, 2013
Symptom control and quality of life in LUX-Lung 3: a phase III study of afatinib or cisplatin/pemetrexed in patients with advanced lung adenocarcinoma with EGFR mutationsJames Chih-Hsin Yang, Vera Hirsh, Martin Schuler, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2008
Radiotherapy in lung adenocarcinoma with brain metastases: effects of activating epidermal growth factor receptor mutations on clinical responseChien-Hung Gow, Chun-Ru Chien, Yih-Leong Chang, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 4, 2014
Chlorhexidine for the prevention of bloodstream infection associated with totally implantable venous ports in patients with solid cancersHsiang-Fong Kao, I-Chun Chen, Chiun Hsu, et al.Lung Cancer (Amsterdam, Netherlands)|December 11, 2025
MAGELLAN arms B1 and B3: Durvalumab plus chemotherapy with and without oleclumab in treatment-naïve metastatic non-small-cell lung cancerByoung Chul Cho, Chaiyut Charoentum, Dong-Wan Kim, et al.Journal of Magnetic Resonance Imaging : JMRI|April 21, 2012
Dynamic contrast-enhanced MRI in advanced nonsmall-cell lung cancer patients treated with first-line bevacizumab, gemcitabine, and cisplatinYeun-Chung Chang, Chong-Jen Yu, Chung-Ming Chen, et al.Pageof 33